Jasmine Foo
Jasmine Foo
Professor of Mathematics, University of Minnesota
Verified email at - Homepage
Cited by
Cited by
Optimization of dosing for EGFR-mutant non–small cell lung cancer with evolutionary cancer modeling
J Chmielecki, J Foo, GR Oxnard, K Hutchinson, K Ohashi, R Somwar, ...
Science translational medicine 3 (90), 90ra59-90ra59, 2011
Evolution of acquired resistance to anti-cancer therapy
J Foo, F Michor
Journal of theoretical biology 355, 10-20, 2014
The multi-element probabilistic collocation method (ME-PCM): Error analysis and applications
J Foo, X Wan, GE Karniadakis
Journal of Computational Physics 227 (22), 9572-9595, 2008
Multi-element probabilistic collocation method in high dimensions
J Foo, GE Karniadakis
Journal of Computational Physics 229 (5), 1536-1557, 2010
A physical sciences network characterization of non-tumorigenic and metastatic cells
Scientific reports 3 (1), 1449, 2013
Intratumor heterogeneity in evolutionary models of tumor progression
R Durrett, J Foo, K Leder, J Mayberry, F Michor
Genetics 188 (2), 461-477, 2011
Evolution of resistance to targeted anti-cancer therapies during continuous and pulsed administration strategies
J Foo, F Michor
PLoS computational biology 5 (11), e1000557, 2009
The impact of microenvironmental heterogeneity on the evolution of drug resistance in cancer cells
SM Mumenthaler, J Foo, NC Choi, N Heise, K Leder, DB Agus, W Pao, ...
Cancer informatics 14, CIN. S19338, 2015
Effects of pharmacokinetic processes and varied dosing schedules on the dynamics of acquired resistance to erlotinib in EGFR-mutant lung cancer
J Foo, J Chmielecki, W Pao, F Michor
Journal of Thoracic Oncology 7 (10), 1583-1593, 2012
Evolution of resistance to anti-cancer therapy during general dosing schedules
J Foo, F Michor
Journal of theoretical biology 263 (2), 179-188, 2010
Vortex mode selection of a rigid cylinder subject to VIV at low mass-damping
D Lucor, J Foo, GE Karniadakis
Journal of Fluids and Structures 20 (4), 483-503, 2005
Dose-dependent differential mRNA target selection and regulation by let-7a-7f and miR-17-92 cluster microRNAs
J Shu, Z Xia, L Li, ET Liang, N Slipek, D Shen, J Foo, S Subramanian, ...
RNA biology 9 (10), 1275-1287, 2012
Eradication of chronic myeloid leukemia stem cells: a novel mathematical model predicts no therapeutic benefit of adding G-CSF to imatinib
J Foo, MW Drummond, B Clarkson, T Holyoake, F Michor
PLoS Computational Biology 5 (9), e1000503, 2009
Stochastic dynamics of cancer initiation
J Foo, K Leder, F Michor
Physical biology 8 (1), 015002, 2011
Fitness Conferred by BCR-ABL Kinase Domain Mutations Determines the Risk of Pre-Existing Resistance in Chronic Myeloid Leukemia
K Leder, J Foo, B Skaggs, M Gorre, CL Sawyers, F Michor
PloS one 6 (11), e27682, 2011
Evolutionary dynamics of tumor progression with random fitness values
R Durrett, J Foo, K Leder, J Mayberry, F Michor
Theoretical population biology 78 (1), 54-66, 2010
A high-content image-based method for quantitatively studying context-dependent cell population dynamics
CM Garvey, E Spiller, D Lindsay, CT Chiang, NC Choi, DB Agus, ...
Scientific reports 6 (1), 29752, 2016
Evolutionary modeling of combination treatment strategies to overcome resistance to tyrosine kinase inhibitors in non-small cell lung cancer
SM Mumenthaler, J Foo, K Leder, NC Choi, DB Agus, W Pao, P Mallick, ...
Molecular pharmaceutics 8 (6), 2069-2079, 2011
Selection pressure exerted by imatinib therapy leads to disparate outcomes of imatinib discontinuation trials
M Tang, J Foo, M Gönen, J Guilhot, FX Mahon, F Michor
haematologica 97 (10), 1553, 2012
Understanding the role of phenotypic switching in cancer drug resistance
EB Gunnarsson, S De, K Leder, J Foo
Journal of theoretical biology 490, 110162, 2020
The system can't perform the operation now. Try again later.
Articles 1–20